CClinicalTrials.gg
CompletedNCT04600310Updated Oct 23, 2020

ULTRAPREP Used to Perform Skin Antisepsis Outside the Operating Room

An interventional study of ULTRAPREP and No Intervention in Time Saved Performing Skin Antisepsis Process Outside the OR and Antisepsis of Skin Preparation Outside the OR, sponsored by Prep Tech, LLC. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-10-23.

Sponsored by Prep Tech, LLC · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was Jan 2019, 7 years 8 months ago, and no results have been posted to the registry.
  • Registered 2 years 5 months after the study started (first participant enrolled Apr 2018, registered Sep 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Testing ULTRAPREP (consists of a clear bag sealed on one end with the other end enclosing the patients extremity) for safety and efficacy to perform skin antisepsis outside the operating room.

Read the detailed description

The purpose of the study is to determine if ULTRAPREP is equal to or better than the conventional methods of preoperative skin antisepsis (the technique of cleansing the skin to help prevent infection) in surgical cases. The study will also help determine if ULTRAPREP will decrease the total amount of time in the operating room. The study will focus on whether or not using ULTRAPREP provides better patient flow and patient safety while improving a surgical staff's workload and workflow. The study includes 2 study arms:

Study Arm #1: the conventional method (or standard of care) will use an accepted skin disinfectant solution with ChloraPrep (70% isopropyl alcohol and 2% chlorhexidine). The solution is "painted" on the patient's skin using a sponge on a stick. The application time is with this method is 3 minutes plus 3 minutes for solution to evaporate. This is a widely-accepted method used in ORs. The preparation process is performed by surgical staff in the OR prior to surgery.

Study Arm #2: using ULTRAPREP bag containing ChloraPrep (70% isopropyl alcohol and 2% chlorhexidine). The bag will be placed on the patient's lower extremity in the holding area. The lower extremity will be scrubbed for 3 minutes. Once the patient is transferred to the OR, the solution will be suctioned out of the bag and the bag removed from the lower extremity to allow the solution to evaporate, this process take 3 minutes. the patient is then draped for surgery.

This study consists of 57 patients in each arm.

Sterile culture swabs will be taken from toenail beds and between toes or from fingernail beds and between fingers, depending on surgery site. The cultures will be taken preoperative before any disinfecting has begun and just before patient extremity is draped (after allowing 3 minutes for alcohol in disinfectant to evaporate). These sterile swabs will be taken to the lab for aliquot culturing to yield 6 pitre dishes for each swab. The CFUs (colony forming units) from each pitre dish will be counted and analyzed at 48 and 72 hours. A comparison will be made using the cultures in Arm 1 and Arm 2 to determine if the parameters of the study has been met.

02

Conditions studied

  • Time Saved Performing Skin Antisepsis Process Outside the OR
  • Antisepsis of Skin Preparation Outside the OR

Keywords

  • skin antisepsis
  • OR efficiency
03

In context

Lead sponsor

This is the only study on the registry with Prep Tech, LLC as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 or older
  • Class 1 clean (as defined by The American College of Surgeons)
  • Hand and Feet extremities

Exclusion criteria

Exclusion Criteria:

  • Open wounds
  • Pregnant
  • Emergency surgeries
  • Class 2-4 (as defined by The American College of Surgeons)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
114 participants (actual)

Study arms

  • Other
    Study Arm 1 Conventional Prep/Control

    The preoperative preparation for the control group will use ChloraPrep (2% chlorhexidine and 70% isopropyl alcohol) that will be applied to the skin using a sponge-on-a-stick method; this solution is widely recognized as optimal. After the alcohol-based solution has evaporated (no less than 3 minutes), the patient extremity is draped for surgery.

    Device: No Intervention

  • Other
    Study Arm 2 ULTRAPREP Group/Intervention Arm

    ChloraPrep (2% chlorhexidine and 70% isopropyl alcohol) will be poured into the ULTRAPREP bag which will be placed on the patient's extremity while in the holding area; it will be removed only after scrub time of 3 minutes is complete and the patient has been transferred to the OR, anesthetized, and positioned. The patient is draped only after the solution has evaporated (no less than 3 minutes).

    Device: ULTRAPREP

Interventions

  • DeviceULTRAPREP

    ULTRAPREP device for reducing OR prep times.

  • DeviceNo Intervention

    Conventional skin preparation technique

06

What researchers measure

Primary outcomes

  1. Change in Time: Room to drape

    Minutes elapsed from patient ready for prep and ready for draping

    Time frame: Up to 60 minutes

  2. Change in Time: ULTRAPREP bag use

    Minutes elapsed from ULTRAPREP placed on extremity to scrubbing complete

    Time frame: Up to 60 minutes

  3. Colony forming units (CFU) Pre-Prep 48h

    CFUs of bacteria per plate, collected upon arrival to pre-op area, measured after 48 hours growth

    Time frame: 48 hours after collection

  4. Colony forming units (CFU) Pre-Prep 72h

    CFUs of bacteria per plate, collected upon arrival to pre-op area, measured after 72 hours growth

    Time frame: 72 hours after collection

  5. Colony forming units (CFU) Post-Prep 48h

    CFUs of bacteria per plate, collected prior to draping, measured after 48 hours growth

    Time frame: 48 hours after collection

  6. Colony forming units (CFU) Post-Prep 72h

    CFUs of bacteria per plate, collected prior to draping, measured after 72 hours growth

    Time frame: 72 hours after collection

07

Study locations

1 site
  • PrepTech, LLC
    Westlake, Louisiana 70669, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04600310
Lead sponsor
Prep Tech, LLC
Responsible party
Mallory M. Przybylski, DPM, MSc (Principal Investigator, Prep Tech, LLC) — Principal investigator
First posted
Oct 23, 2020
Start date
Apr 17, 2018
Primary completion
Jan 17, 2019
Completion
Jan 17, 2019
Last update
Oct 23, 2020

Study contacts

Pete Prados, Business
study director · PrepTech, LLC

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion